stifteverband aesku kleinAESKU receives "Innovative through Research" award - Stifterverband für die deutsche Wissenschaft awards research seal

Since 2014, the Stifterverband acknowledges research companies that embrace their special responsibility for state and society with the "Innovative through Research" seal. Now Aesku.Diagnostics has received the award for its research competence and innovative abilities. Read more...


aesqc ifa promo image

ICAP Compatible IFA Quality Controls Now Available from AESKU

AESKU announces a new ICAP compatible Immunofluorescence Assay (IFA) Quality Control (QC) product line and supporting Quality Assurance tool,, to help laboratories identify, correct, and prevent analytical failure prior to releasing results. Read more...


AESKU.GROUP Lab Automation - Worldwide Installations Overview

Installations worldwide
Countries with Installations


HELIOS Introduction (English Language)


FDA clears Automated Vasculitis Test from AESKU

AESKU Receives FDA 510(k) Clearance for Anti-Neutrophil Cytoplasmic Antibody (ANCA) test to aid in the Diagnosis of ANCA Associated Vasculitides with the HELIOS Automated immunofluorescence assay (IFA) System

(Wendelsheim, Germany / Oakland, California) AESKU.GROUP – a science-focused manufacturer of autoimmune, allergy, and infectious disease diagnostics – received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AESKUSLIDES ANCA Ethanol, and ANCA Formalin with the new HELIOS AUTOMATED IFA SYSTEM. Next to be submitted are esophageal and tissue section slides. Read more...


aesku booth medlab 2018

MEDLAB 2018 - AESKU.GROUP highlights from the premier global laboratory and diagnostics conference in Dubai

Thanks to all who visited us during the 2018 MEDLAB conference, and "Vielen Dank" to the conference organizers for the successful show. Read more...


nDNA (Crithidia luciliae) now FDA cleared with HELIOS System

AESKU Receives FDA 510(k) Clearance for nDNA (Crithidia luciliae) with the HELIOS AUTOMATED IFA SYSTEM.

(Wendelsheim, Germany / Oakland, California,) AESKU.GROUP received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AESKUSLIDES nDNA (Crithidia luciliae) with the new HELIOS AUTOMATED IFA SYSTEM. The kit is the second FDA cleared immunofluorescence assay on the HELIOS, after ANA HEp-2 (cleared in 2016), and will be followed by ANCA and tissue section slides. Read more...


aacc 2017 booth klein

AACC 2017 - AESKU.GROUP wraps up another successful conference

We would like to thank everyone who visited us during the 2017 AACC conference and expo last month. For those who were unable to make it to San Diego, here are a few selected highlights:



helios linkedin premier

Premier Inc. Spotlights AESKU HELIOS at Annual Conference!

The AESKU HELIOS distributed by Grifols in the US, was showcased among 17 other cutting-edge healthcare products and groundbreaking startup companies on Tuesday night at its annual Innovation Celebration.



HNL chooses HELIOS for complete IFA Automation of ANA testing

hnl interview image sHealth Network Laboratories (HNL), a regional leader in laboratory medicine, provides high quality personalized laboratory services in Eastern PA and Southern NJ. 

The immunology laboratory at HNL is led by Kimberly Pacella, Director of Clinical Operations. Kim and her team decided to implement the AESKU HELIOS, distributed in the US by Grifols Diagnostics Solutions. The HELIOS, a revolutionary new platform that employs automated immunofluorescence (IFA) technology to process and analyze patient samples, is the first clinical platform to offer the highest level of automation.


DST Logo AESKU.GROUP acquires DST Diagnostische Systeme & Technologien GmbH

Wendelsheim / Schwerin - AESKU.GROUP, an innovation leader in autoimmune diagnostics, is taking over the allergy specialists DST Diagnostische Systeme & Technologien GmbH, thereby expanding its product portfolio to include allergy and food intolerance diagnostics.

Open english Version | Zur deutschen Version wechseln



AESKU.GROUP offers a complete reagent and automation panel for fast and reliable detection of several diseases. With over 240 dedicated employees across our AESKU.DIAGNOSTICS, AESKU.SYSTEMS, AESKU.KIPP INSTITUTE and AESKU.THERAPY divisions, AESKU provides comprehensive and expert solutions to laboratories of any size.